Chimera Investment Stock Forecast, Price & News

Chimera Investment's stock was trading at $18.36 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CIM stock has decreased by 52.0% and is now trading at $8.82.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chimera Investment in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Chimera Investment.

Chimera Investment is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Chimera Investment.

Chimera Investment will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Chimera Investment Co. (NYSE:CIM) released its earnings results on Wednesday, August, 5th. The real estate investment trust reported $0.32 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.31 by $0.01. Chimera Investment had a positive return on equity of 11.88% and a negative net margin of 17.05%. During the same period in the previous year, the firm earned $0.53 earnings per share.
View Chimera Investment's earnings history.

Chimera Investment declared a quarterly dividend on Tuesday, September 15th. Investors of record on Tuesday, September 29th will be paid a dividend of $0.30 per share on Thursday, October 29th. This represents a $1.20 annualized dividend and a dividend yield of 13.61%. The ex-dividend date is Monday, September 28th.
View Chimera Investment's dividend history.

4 brokers have issued twelve-month price objectives for Chimera Investment's shares. Their forecasts range from $9.00 to $12.00. On average, they expect Chimera Investment's stock price to reach $10.33 in the next twelve months. This suggests a possible upside of 17.2% from the stock's current price.
View analysts' price targets for Chimera Investment.

Some companies that are related to Chimera Investment include ANNALY CAP MGMT/SH (NLY), AGNC Investment (AGNC), Starwood Property Trust (STWD), PennyMac Mortgage Investment Trust (PMT), Colony Capital (CLNY), Two Harbors Investment (TWO), Apollo Commercial Real Estate Finance (ARI), MFA Financial (MFA), New York Mortgage Trust (NYMT), Redwood Trust (RWT), ARMOUR Residential REIT (ARR), Ready Capital (RC), Capstead Mortgage (CMO), Invesco Mortgage Capital (IVR) and Dynex Capital (DX).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Chimera Investment investors own include New Residential Investment (NRZ), ANNALY CAP MGMT/SH (NLY), Marathon Oil (MRO), AGNC Investment (AGNC), Energy Transfer (ET), AT&T (T), ARMOUR Residential REIT (ARR), New York Mortgage Trust (NYMT), Enterprise Products Partners (EPD) and NGL Energy Partners (NGL).

Chimera Investment trades on the New York Stock Exchange (NYSE) under the ticker symbol "CIM."

Chimera Investment's stock is owned by a number of retail and institutional investors. Top institutional shareholders include LSV Asset Management (1.15%), Envestnet Asset Management Inc. (0.08%), Pegasus Asset Management Inc. (0.07%), Nisa Investment Advisors LLC (0.06%), Ziegler Capital Management LLC (0.04%) and Avantax Advisory Services Inc. (0.04%). Company insiders that own Chimera Investment stock include Choudhary Yarlagadda, Matthew Lambiase, Paul Donlin, Phillip John Kardis II and Robert S Colligan.
View institutional ownership trends for Chimera Investment.

CIM stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, James Investment Research Inc., and Great Valley Advisor Group Inc..
View insider buying and selling activity for Chimera Investment.

CIM stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Pegasus Asset Management Inc., Avantax Advisory Services Inc., Nisa Investment Advisors LLC, Chicago Capital LLC, Clear Street Markets LLC, Concorde Asset Management LLC, and Ziegler Capital Management LLC. Company insiders that have bought Chimera Investment stock in the last two years include Choudhary Yarlagadda, Matthew Lambiase, Paul Donlin, Phillip John Kardis II, and Robert S Colligan.
View insider buying and selling activity for Chimera Investment.

Shares of CIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CIM stock can currently be purchased for approximately $8.82.

Chimera Investment has a market capitalization of $2.05 billion and generates $1.36 billion in revenue each year. The real estate investment trust earns $413.55 million in net income (profit) each year or $2.25 on an earnings per share basis. Chimera Investment employs 39 workers across the globe.

The official website for Chimera Investment is www.chimerareit.com.

Chimera Investment's mailing address is 520 MADISON AVENUE 32ND FLOOR, NEW YORK NY, 10022. The real estate investment trust can be reached via phone at 212-626-2300 or via email at [email protected]